Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes.

Andersson C, Lyngbæk S, Nguyen CD, Nielsen M, Gislason GH, Køber L, Torp-Pedersen C.

JAMA. 2012 Sep 5;308(9):882-9. doi: 10.1001/2012.jama.10779.

PMID:
22948698
[PubMed - indexed for MEDLINE]
2.

Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction.

Sørensen R, Abildstrøm SZ, Hansen PR, Hvelplund A, Andersson C, Charlot M, Fosbøl EL, Køber L, Madsen JK, Gislason GH, Torp-Pedersen C.

J Am Coll Cardiol. 2011 Mar 8;57(10):1202-9. doi: 10.1016/j.jacc.2010.09.069.

PMID:
21371637
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction.

Solomon MD, Go AS, Shilane D, Boothroyd DB, Leong TK, Kazi DS, Chang TI, Hlatky MA.

J Am Coll Cardiol. 2014 Jun 3;63(21):2249-57. doi: 10.1016/j.jacc.2014.02.586. Epub 2014 Apr 2.

PMID:
24703914
[PubMed - indexed for MEDLINE]
4.

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.

Gurbel PA, Erlinge D, Ohman EM, Neely B, Neely M, Goodman SG, Huber K, Chan MY, Cornel JH, Brown E, Zhou C, Jakubowski JA, White HD, Fox KA, Prabhakaran D, Armstrong PW, Tantry US, Roe MT; TRILOGY ACS Platelet Function Substudy Investigators.

JAMA. 2012 Nov 7;308(17):1785-94. doi: 10.1001/jama.2012.17312.

PMID:
23117779
[PubMed - indexed for MEDLINE]
5.

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD).

Boggon R, van Staa TP, Timmis A, Hemingway H, Ray KK, Begg A, Emmas C, Fox KA.

Eur Heart J. 2011 Oct;32(19):2376-86. doi: 10.1093/eurheartj/ehr340. Epub 2011 Aug 29.

PMID:
21875855
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, Puri S, Robbins M, Garratt KN, Bertrand OF, Stillabower ME, Aragon JR, Kandzari DE, Stinis CT, Lee MS, Manoukian SV, Cannon CP, Schork NJ, Topol EJ; GRAVITAS Investigators.

JAMA. 2011 Mar 16;305(11):1097-105. doi: 10.1001/jama.2011.290. Erratum in: JAMA. 2011 Jun 1;305(21);2174. Stillablower, Michael E [corrected to Stillabower, Michael E].

PMID:
21406646
[PubMed - indexed for MEDLINE]
7.

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.

Lamberts M, Gislason GH, Olesen JB, Kristensen SL, Schjerning Olsen AM, Mikkelsen A, Christensen CB, Lip GY, Køber L, Torp-Pedersen C, Hansen ML.

J Am Coll Cardiol. 2013 Sep 10;62(11):981-9. doi: 10.1016/j.jacc.2013.05.029. Epub 2013 Jun 7.

PMID:
23747760
[PubMed - indexed for MEDLINE]
Free Article
8.

Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry.

Simon T, Steg PG, Gilard M, Blanchard D, Bonello L, Hanssen M, Lardoux H, Coste P, Lefèvre T, Drouet E, Mulak G, Bataille V, Ferrières J, Verstuyft C, Danchin N.

Circulation. 2011 Feb 8;123(5):474-82. doi: 10.1161/CIRCULATIONAHA.110.965640. Epub 2011 Jan 24.

PMID:
21262992
[PubMed - indexed for MEDLINE]
Free Article
9.

Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.

Charlot M, Ahlehoff O, Norgaard ML, Jørgensen CH, Sørensen R, Abildstrøm SZ, Hansen PR, Madsen JK, Køber L, Torp-Pedersen C, Gislason G.

Ann Intern Med. 2010 Sep 21;153(6):378-86. doi: 10.7326/0003-4819-153-6-201009210-00005. Erratum in: Ann Intern Med. 2011 Jan 4;154(1):76.

PMID:
20855802
[PubMed - indexed for MEDLINE]
10.

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.

Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Lewis BS, Murphy SA, McCabe CH, Braunwald E; Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators.

JAMA. 2005 Sep 14;294(10):1224-32. Epub 2005 Sep 4.

PMID:
16143698
[PubMed - indexed for MEDLINE]
11.

High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.

Parodi G, Marcucci R, Valenti R, Gori AM, Migliorini A, Giusti B, Buonamici P, Gensini GF, Abbate R, Antoniucci D.

JAMA. 2011 Sep 21;306(11):1215-23. doi: 10.1001/jama.2011.1332.

PMID:
21934054
[PubMed - indexed for MEDLINE]
12.

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM.

JAMA. 2007 Jan 10;297(2):159-68. Epub 2006 Dec 5.

PMID:
17148711
[PubMed - indexed for MEDLINE]
13.

Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study.

Jørgensen CH, Gislason GH, Andersson C, Ahlehoff O, Charlot M, Schramm TK, Vaag A, Abildstrøm SZ, Torp-Pedersen C, Hansen PR.

Cardiovasc Diabetol. 2010 Sep 16;9:54. doi: 10.1186/1475-2840-9-54.

PMID:
20843380
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation.

JAMA. 2002 Nov 20;288(19):2411-20. Erratum in: JAMA. 2003 Feb 26;289(8):987..

PMID:
12435254
[PubMed - indexed for MEDLINE]
15.

Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.

Mahabaleshwarkar RK, Yang Y, Datar MV, Bentley JP, Strum MW, Banahan BF, Null KD.

Curr Med Res Opin. 2013 Apr;29(4):315-23. doi: 10.1185/03007995.2013.772051. Epub 2013 Feb 11.

PMID:
23362935
[PubMed - indexed for MEDLINE]
16.

Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).

Ojeifo O, Wiviott SD, Antman EM, Murphy SA, Udell JA, Bates ER, Mega JL, Sabatine MS, O'Donoghue ML.

JACC Cardiovasc Interv. 2013 Dec;6(12):1275-81. doi: 10.1016/j.jcin.2013.06.014. Epub 2013 Nov 13.

PMID:
24239201
[PubMed - indexed for MEDLINE]
Free Article
17.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

PMID:
21888837
[PubMed - indexed for MEDLINE]
Free Article
18.

Glyburide increases risk in patients with diabetes mellitus after emergent percutaneous intervention for myocardial infarction--a nationwide study.

Jørgensen CH, Gislason GH, Bretler D, Sørensen R, Norgaard ML, Hansen ML, Schramm TK, Abildstrom SZ, Torp-Pedersen C, Hansen PR.

Int J Cardiol. 2011 Nov 3;152(3):327-31. doi: 10.1016/j.ijcard.2010.07.027. Epub 2010 Aug 24.

PMID:
20797803
[PubMed - indexed for MEDLINE]
19.

Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study.

Sørensen R, Gislason GH, Fosbøl EL, Rasmussen S, Køber L, Madsen JK, Torp-Pedersen C, Abildstrom SZ.

Br J Clin Pharmacol. 2008 Dec;66(6):875-84. doi: 10.1111/j.1365-2125.2008.03284.x. Epub 2008 Sep 23.

PMID:
18823305
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study.

Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, Lindhardsen J, Madsen JK, Køber L, Torp-Pedersen C, Gislason GH.

BMJ. 2011 May 11;342:d2690. doi: 10.1136/bmj.d2690.

PMID:
21562004
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk